Results 91 to 100 of about 1,228,094 (210)

SUCCESSFUL LONG-TERM CONTROL OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH ETOPOSIDE

open access: yes, 1991
A 38-year-old man with idiopathic hypereosinophilic syndrome had an inadequate response to steroids and severe side effects from hydroxyurea treatment, which necessitated withdrawal of the treatment. Successful control of clinical symptoms and eosinophil
SMIT, AJ   +2 more
core   +1 more source

Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2010
Renal involvement is rarely reported and little is known about the renal morpho-logic changes in the idiopathic hypereosinophilic syndromes. We reported a case of a 52-year-old man with idiopathic hypereosinophilic syndrome associated with membranous ...
Frigui Makram   +5 more
doaj  

The interleukin-5 messenger RNA expression in a patient with idiopathic hypereosinophilic syndrome

open access: yes, 1998
Interleukin-5 has a specific role in various eosinophilic activities. It is the predominant cytokine produces by activated T-lymphocytes isolated from patients with idiopathic hypereosinophilic syndrome.
Ho, ASS   +4 more
core   +1 more source

Eosinophilic pancreatitis versus pancreatitis associated with eosinophilic gastroenteritis – a systematic review regarding clinical features and diagnosis

open access: yesRomanian Journal of Internal Medicine, 2019
Background. Over the past years, eosinophil infiltration involving the gastrointestinal tract and pancreas leading to eosinophilic pancreatitis, eosinophilic gastroenteritis and hypereosinophilic syndrome has been reported in the literature.
Pinte Larisa, Băicuș Cristian
doaj   +1 more source

Clonal eosinophilia with exclusive pulmonary involvement driven by PDGFRA rearrangement treated with imatinib: A case report

open access: yesLeukemia Research Reports
Hypereosinophilic syndrome (HES) was first described in 1968 by Hardy and Anderson. It is a group of rare, multisystemic and heterogeneous pathologies, characterized by significant morbidity and mortality.
Zaineb Mlayah   +5 more
doaj   +1 more source

An Uncommon Case of Eosinophilic Myocarditis in a Patient With Autoimmune Lymphoproliferative Syndrome

open access: yesAnnals of Internal Medicine: Clinical Cases
Eosinophilic myocarditis is a rare but well-described inflammatory condition with high morbidity and mortality but is not reported as caused by underlying autoimmune lymphoproliferative disorder.
Maria T. Gamero   +6 more
doaj   +1 more source

Factor V Leiden mutation and deep venous thrombosis in a patient with hypereosinophilic syndrome

open access: yes, 2006
Idiopathic hypereosinophilic syndrome is a rare condition characterized by extremely high peripheral blood eosinophil counts. Patients with idiopathic hypereosinophilic syndrome are at increased risk for thrombosis.
Aslan, Vahap, Entok, Emre
core  

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

open access: yes, 2016
The hypereosinophilic syndrome is a group of diseases characterized by persistent blood eosinophilia, defined as more than 1500 cells per microliter with end-organ involvement and no recognized secondary cause.
Parkin, Jacqueline M.   +13 more
core   +1 more source

Paediatric presentation of cardiac involvement in hypereosinophilic syndrome

open access: yes, 2017
Eosinophilic endomyocarditis is extremely rare in paediatrics. This case report aims to present the sequential changes from thrombotic to fibrotic stages of the cardiac involvement in a child with hypereosinophilic syndrome.
Jacquemart, Caroline   +3 more
core   +1 more source

Idiopathic hypereosinophilic syndrome: A case evolving in B-lymphoblastic lymphoma

open access: yes, 2005
Idiopathic hypereosinophilic syndrome (HES) is a rare disease characterized by tissue involvement and organ dysfunction due to abnormal eosinophil proliferation. Evolution of HES into myeloid or T-cell malignancies has been frequently reported.
Coletti, V   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy